Artículos por temáticas

Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes

Sun M, Wang X, Lu Z, Yang Y, Lv S, Miao M, Chen WM, Wu SY, Zhang J.

Diabetes Metab. 2025 Mar;51(2):101623. doi: 10.1016/j.diabet.2025.101623. Epub 2025 Feb 12.

Drug repurposing using artificial intelligence, molecular docking, and hybrid approaches: A comprehensive review in general diseases vs Alzheimer's disease

Zulhafiz NA, Teoh TC, Chin AV, Chang SW.

Comput Methods Programs Biomed. 2025 Apr;261:108604. doi: 10.1016/j.cmpb.2025.108604. Epub 2025 Jan 13.

Drugs repurposing in the experimental models of Alzheimer's disease

Joodi SA, Ibrahim WW, Khattab MM.

Inflammopharmacology. 2025 Jan;33(1):195-214. doi: 10.1007/s10787-024-01608-7. Epub 2025 Jan 3.

Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis

Jiang M, Chi J, Qiao Y, Wang J, Zhang Z, Liu J, Sheng X, Yuan L.

Pharmacol Res. 2025 Feb;212:107578. doi: 10.1016/j.phrs.2025.107578. Epub 2025 Jan 3.

Molecular Mechanisms of Alzheimer's Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy

Ahn EH, Park JB.

Cells. 2025 Jan 10;14(2):89. doi: 10.3390/cells14020089.

Effects of Yoga-Like Exercises on Mild and Moderate Alzheimer Disease: A Randomized Controlled Trial Protocol

Moncer R, Hajji H, Naija S, Ben Amor S, Jemni S, Ben Saad H.

Tunis Med. 2025 Jan 5;103(1):58-64. doi: 10.62438/tunismed.v103i1.5341.

Expert opinion on Centiloid thresholds suitable for initiating anti-amyloid therapy. Summary of discussion at the 2024 spring Alzheimer's Association Research Roundtable

Farrar G, Weber CJ, Rabinovici GD.

J Prev Alzheimers Dis. 2025 Jan;12(1):100008. doi: 10.1016/j.tjpad.2024.100008. Epub 2025 Jan 1.

Twelve weeks of exercise training improves cognitive status, physical performance and quality of life in Alzheimer's disease: A systematic review and meta-analysis

de Sá Leitão CVF, Moraes BF, Leite GAPD, Duarte AG, da Silva MVG, de Oliveira GM, Andrade FAB, da Silva JAB, Dos Santos RCC, Figueiredo GS, Campos HO, Leite LHR, Drummond LR, Coimbra CC.

Ageing Res Rev. 2025 Feb;104:102655. doi: 10.1016/j.arr.2025.102655. Epub 2025 Jan 10.

Natural products against tau hyperphosphorylation-induced aggregates: Potential therapies for Alzheimer's disease

Basurto-Islas G, Diaz MC, Ocampo LMZ, Martínez-Herrera M, López-Camacho PY.

Arch Pharm (Weinheim). 2025 Jan;358(1):e2400721. doi: 10.1002/ardp.202400721.

Unlocking the Therapeutic Potential of Natural Products for Alzheimer's Disease

Li Z, Zhang Z, Yu B.

J Med Chem. 2025 Feb 13;68(3):2377-2402. doi: 10.1021/acs.jmedchem.4c03049. Epub 2025 Jan 26.

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

Smith EE, Phillips NA, Feldman HH, Borrie M, Ganesh A, Henri-Bhargava A, Desmarais P, Frank A, Badhwar A, Barlow L, Bartha R, Best S, Bethell J, Bhangu J, Black SE, Bocti C, Bronskill SE, Burhan AM, C

J Prev Alzheimers Dis. 2025 Mar;12(3):100068. doi: 10.1016/j.tjpad.2025.100068. Epub 2025 Jan 31.

1,3,5-Triazine: A Promising Molecular Scaffold for Novel Agents for the Treatment of Alzheimer's Disease

Silva CFM, Guerrinha APDMS, Carvalho S, Pinto DCGA, Silva AMS.

Int J Mol Sci. 2025 Jan 21;26(3):882. doi: 10.3390/ijms26030882.

Exploring Quinazoline as a Scaffold for Developing Novel Therapeutics in Alzheimer's Disease

Abualassal Q, Abudayeh Z, Sirhan A, Mkia A.

Molecules. 2025 Jan 26;30(3):555. doi: 10.3390/molecules30030555.

Deciphering the Role of Adrenergic Receptors in Alzheimer's Disease: Paving the Way for Innovative Therapies

Miliotou AN, Kotsoni A, Zacharia LC.

Biomolecules. 2025 Jan 15;15(1):128. doi: 10.3390/biom15010128.

Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study

Wang S, Xi J, Zhang M, Wang J.

Int J Biol Macromol. 2025 Mar;294:139394. doi: 10.1016/j.ijbiomac.2024.139394. Epub 2025 Jan 3.